Symptomatic treatment of seasonal or perennial allergic rhinitis.
Dosage and Administration
General
For therapeutic effectiveness, use at regular intervals.
Administration
Intranasal Inhalation
Administer by nasal inhalation using a metered-dose pump spray.
Shake inhaler gently immediately prior to use.
Prior to initial use, the metered-dose pump spray must be primed with 8 actuations.
If spray pump is not used for 2 consecutive days, partially prime (1 actuation or until a fine spray is observed). If the spray pump is not used for more than 14 days, rinse the applicator and reprime with 2 sprays or until a fine spray appears. Rinse the applicator when not used for more than 14 days.
Clear nasal passages prior to administration.
Tilt the head slightly forward, insert the spray tip into one nostril, and point the tip toward the back of the nose. Pump the drug into one nostril while holding the other nostril closed and concurrently inspire through the nose. Repeat this procedure for the other nostril.
Dosage
After priming, nasal spray pump delivers about 32 mcg of budesonide per metered spray and about 120 metered doses per 8.6-g container.
Pediatric Patients
Titrate dosage to the lowest possible effective level. (See Pediatric Use under Cautions.)
Seasonal Allergic Rhinitis
Intranasal Inhalation
Children 6–11 years of age: initially, 32 mcg (1 spray) in each nostril once daily (64 mcg total). May be increased to 64 mcg (2 sprays) in each nostril once daily (128 mcg total).
Children ≥12 years of age: initially, 32 mcg (1 spray) in each nostril once daily (64 mcg total). May be increased to 128 mcg (4 sprays) in each nostril once daily (256 mcg total).
Perennial Allergic Rhinitis
Intranasal Inhalation
Children 6–11 years of age: initially, 32 mcg (1 spray) in each nostril once daily (64 mcg total). May be increased to 64 mcg (2 sprays) in each nostril once daily (128 mcg total).
Children ≥12 years of age: initially, 32 mcg (1 spray) in each nostril once daily (64 mcg total). May be increased to 128 mcg (4 sprays) in each nostril once daily (256 mcg total).
Adults
Seasonal Allergic Rhinitis
Intranasal Inhalation
Initially, 32 mcg (1 spray) in each nostril once daily (64 mcg total). May be increased to 128 mcg (4 sprays) in each nostril once daily (256 mcg total).
Perennial Allergic Rhinitis
Intranasal Inhalation
Initially, 32 mcg (1 spray) in each nostril once daily (64 mcg total). May be increased to 128 mcg (4 sprays) in each nostril once daily (256 mcg total).
Prescribing Limits
Pediatric Patients
Seasonal Allergic Rhinitis
Intranasal Inhalation
Children 6–11 years of age: maximum 128 mcg (2 sprays in each nostril) once daily.
Children ≥12 years of age: maximum 256 mcg (4 sprays in each nostril) once daily.
Perennial Allergic Rhinitis
Intranasal Inhalation
Children 6–11 years of age: maximum 128 mcg (2 sprays in each nostril) once daily.
Children ≥12 years of age: maximum 256 mcg (4 sprays in each nostril) once daily.
Adults
Seasonal Allergic Rhinitis
Intranasal Inhalation
Maximum 256 mcg (4 sprays in each nostril) once daily.
Perennial Allergic Rhinitis
Intranasal Inhalation
Maximum 256 mcg (4 sprays in each nostril) once daily.
Drug Info Tools
